Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice
{{output}}
Hepatocellular carcinoma is a challenging malignancy of global importance. It is the sixth most common solid malignancy and the third leading cause of cancer-related death, worldwide. Curative treatments at early stages include liver transplantation, resection... ...